FDA Expands Sogroya Approval; Record Obesity Rates in Kids; Cushing's and Depression

(MedPage Today) — The FDA expanded the indication of the long-acting growth hormone somapacitan (Sogroya) to include very young children with idiopathic short stature, short stature born small for gestational age, or growth failure associated…

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/120143

Author :

Publish date : 2026-03-03 19:42:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

FDA Expands Sogroya Approval; Record Obesity Rates in Kids; Cushing’s and Depression

N.Y. Attorney General Demands Hospital Resume Youth Gender-Affirming Care

FDA Warns 30 Telehealth Firms Over Compounded GLP-1 Medications

Related Posts

Telemedicine Visits Tied to Fewer Antibiotics for Respiratory Infections

Unpacking Higher Cancer Rates in Young Adults; Increasing Vaccine Uptake

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Trump’s New Surgeon General Pick Has Both Praised and Cringed at His Administration

Court Restricts Abortion Access Across U.S. by Blocking the Mailing of Mifepristone

Your Dreams May Influence Your Morning Mood. Here’s Why

Telemedicine Visits Tied to Fewer Antibiotics for Respiratory Infections

Unpacking Higher Cancer Rates in Young Adults; Increasing Vaccine Uptake

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Trump’s New Surgeon General Pick Has Both Praised and Cringed at His Administration

Court Restricts Abortion Access Across U.S. by Blocking the Mailing of Mifepristone

Your Dreams May Influence Your Morning Mood. Here’s Why

FDA Approves First Non-Antipsychotic Drug for Alzheimer’s Agitation

Novel Pulsed Field Ablation System Turns to High-Energy, Ultra-Short Zaps

Categories

Archives